Ginsenoside Rb1 containing impurity ginsenoside Rc

A ginsenoside content technology, which is applied to medical preparations containing active ingredients, organic active ingredients, plant raw materials, etc., can solve the problems of no content measurement, high cost, and high cost

Inactive Publication Date: 2009-03-25
PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Ginsenoside Rb 1 A small amount (mg level to g level) is mostly obtained by laboratory methods, such as preparation of high performance liquid chromatography, silica gel column chromatography, etc., for scientific research, but it is impossible to obtain batches (above kg level) of ginsenoside Rb 1 It is used for the development and industrial production of finished medicine, so this is ginsenoside Rb 1 Reasons and Difficulties of Difficult Medicine So far
[0006] Application No. 03127664.4 patent document "environmental protection type ginsenoside Rb 1 High yield industrial separation", this document discloses that ginsenoside Rb with a content greater than 95% can be obtained 1 , using silica gel column chromatography, the method is expensive and difficult to industrialized production; another major problem in this document is that there is no method for analysis and detection to show that ginsenoside Rb 1 The content reaches 95%, and its credibility is doubtful; the patent document "Ginsenoside Rb" with applicatio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ginsenoside Rb1 containing impurity ginsenoside Rc
  • Ginsenoside Rb1 containing impurity ginsenoside Rc
  • Ginsenoside Rb1 containing impurity ginsenoside Rc

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0107] A ginsenoside Rb 1 , Ginsenoside Rb 1 The content is 90.02%, the impurity content is 9.98%, the impurity includes ginsenoside Rc, and the ginsenoside Rc content is 9.95.

[0108] The above ginsenoside as Rb 1 Pharmaceutical raw materials can be prepared into pharmaceutical preparations acceptable to pharmaceutics.

Embodiment 2

[0110] A ginsenoside Rb 1 , Ginsenoside Rb 1 The content is 99.80%, the impurity content is 0.20%, the impurity includes ginsenoside Rc, and the content of ginsenoside Rc is 0.13%.

[0111] The above ginsenoside as Rb 1 Pharmaceutical raw materials can be prepared into pharmaceutical preparations acceptable to pharmaceutics.

Embodiment 3

[0113] A ginsenoside Rb 1 , Ginsenoside Rb 1 The content is 91.82%, the impurity content is 8.18%, the impurity includes ginsenoside Rc, and the content of ginsenoside Rc is 8.09%.

[0114] The above ginsenoside as Rb 1 Pharmaceutical raw materials can be prepared into pharmaceutical preparations acceptable to pharmaceutics.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a standard ginsenoside Rb1 active ingredient, containing ginsenoside Rb1 with the content more than or equal to 90% and less than 100%, is also characterized in that the active ingredient contains ginsenoside Rc with the content more than 0% and less than or equal to 10%; or the content of impurity ginsenoside Rc is more than or equal to 0.05% and less than or equal to 6.5%; or the content of ginsenoside Rc is more than or equal to 0.1% and less than or equal to 5.0%; the content of impurity ginsenoside Rc is more than or equal to 0.1% and less than or equal to 3.0%; Pharmacological experiments show that the standard active ingredient of the application has good pharmacological effects and can be prepared into pharmaceutical preparations in Pharmacy.

Description

Technical field [0001] The present invention relates to the technical field of traditional Chinese medicine, in particular to a standard ginsenoside Rb 1 Active ingredients. [0002] The present invention is to provide a standard active ingredient of traditional Chinese medicine, namely standard ginsenoside Rb containing impurity ginsenoside Rc 1 . Background technique [0003] The application of traditional Chinese medicine has a history of thousands of years and has made a significant contribution to human health. With the increasing use of traditional Chinese medicine, the safety of traditional Chinese medicine has attracted worldwide attention. Due to the particularity of traditional Chinese medicine (such as Complex ingredients, more ingredients, etc.), it is difficult to carry out the monitoring of adverse reactions of traditional Chinese medicine. However, for the health of the majority of patients, the monitoring of adverse reactions will definitely be greatly strengthene...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/704A61K36/258A61P9/00A61P3/06A61P25/28A61P35/00
Inventor 顾群李志刚郭小鹏米长江阮爱华刘严渠守峰金治刚林治荣
Owner PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products